Clinicopathological and prognostic features of primary clear cell carcinoma of the liver

被引:45
作者
Liu, Zhisheng [1 ]
Ma, Weidong [1 ]
Li, Huikai [1 ]
Li, Qiang [1 ]
机构
[1] Tianjin Med Univ, Canc Hosp, Dept Hepatobiliary Surg, Tianjin 300060, Peoples R China
关键词
clear cell carcinoma; hepatitis C virus; hepatocellular carcinoma; prognosis;
D O I
10.1111/j.1872-034X.2007.00264.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: Primary clear cell carcinoma of the liver (PCCCL) is a subgroup of primary hepatocellular carcinoma (HCC), pathologically characterized by diffuse clear cells of the tumor, showing a clear cytoplasm that does not stain with hematoxylin-eosin. At present, its clinicopathological and prognostic features are not fully clarified. This study aims to clarify the clinicopathological and prognostic features of PCCCL. Methods: The clinicopathological data of 43 patients with PCCCL treated with hepatectomy in our hospital from January 1999 to December 2003 were retrospectively analyzed. Results: The chi(2)-test showed a positive rate of hepatitis C virus (HCV) infection and capsule formation in the PCCCL group, which was markedly higher than in the common type HCC (CHCC) group (P = 0.000 and P = 0.005). Meanwhile, the vascular invasion rate was notably lower in the PCCCL group, but there were no significant differences between the twogroups (P = 0.129). The Kaplan-Meier method showed that the 1-, 3-, and 5-year survival rates were significantly higher in the PCCCL group than in the CHCC group (P = 0.021). The prognosis of patients in the PCCCL group was related to capsule formation, vascular invasion, liver cirrhosis, and clear cell ratio. The 1-, 3-, and 5-year survival rates were markedly higher in the group with a higher clear cell ratio than in the group with a lower clear cell ratio (P = 0.011). Conclusion: The notable clinicopathological features of the patients in the PCCCL group included a higher rate of HCV infection, capsule formation, and a lower rate of vascular invasion. The prognosis was better than that of the patients in the CHCC group and related to the ratio of clear cells.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
[1]
Primary clear cell carcinoma of noncirrhotic liver - Immunohistochemical discrimination of hepatocellular and cholangiocellular origin [J].
Adamek, HE ;
Spiethoff, A ;
Kaufmann, V ;
Jakobs, R ;
Riemann, JF .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (01) :33-38
[2]
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[3]
Steatosis in chronic hepatitis C: Why does it really matter? [J].
Asselah, T ;
Rubbia-Brandt, L ;
Marcellin, P ;
Negro, F .
GUT, 2006, 55 (01) :123-130
[4]
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[5]
BUNCHANAN TF, 1974, AM J CLIN PATHOL, V61, P529
[6]
Impact of obesity on treatment of chronic hepatitis C [J].
Charlton, Michael R. ;
Pockros, Paul J. ;
Harrison, Stephen A. .
HEPATOLOGY, 2006, 43 (06) :1177-1186
[7]
Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation [J].
Clouston, AD ;
Jonsson, JR ;
Purdie, DM ;
Macdonald, GA ;
Pandeya, N ;
Shorthouse, C ;
Powell, EE .
JOURNAL OF HEPATOLOGY, 2001, 34 (02) :314-320
[8]
HCV-ASSOCIATED LIVER-CANCER WITHOUT CIRRHOSIS [J].
DEMITRI, MS ;
POUSSIN, K ;
BACCARINI, P ;
PONTISSO, P ;
DERRICO, A ;
SIMON, N ;
GRIGIONI, W ;
ALBERTI, A ;
BEAUGRAND, M ;
PISI, E ;
BRECHOT, C ;
PATERLINI, P .
LANCET, 1995, 345 (8947) :413-415
[9]
DONAT EE, 1991, ACTA CYTOL, V35, P671
[10]
Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma [J].
Emile, JF ;
Lemoine, A ;
Azoulay, D ;
Debuire, B ;
Bismuth, H ;
Reynès, M .
HISTOPATHOLOGY, 2001, 38 (03) :225-231